期刊文献+

基于荧光差异双向电泳的雷帕霉素损伤人冠状动脉内皮细胞的蛋白质组学研究 被引量:2

Proteomics study of rapamycin-injured human coronary artery endothelial cells based on two dimension fluorescence differential gel electrophoresis
下载PDF
导出
摘要 目的利用蛋白质组学的方法系统探索洗脱支架药物雷帕霉素损伤人冠状动脉内皮细胞的蛋白质谱的变化。方法雷帕霉素处理人冠状动脉内皮细胞HCAECs,进行荧光差异双向电泳(2D-DIGE)差异表达蛋白的研究分析,MALDI-ToF-ToF质谱对蛋白质进行鉴定。结果共发现差异蛋白斑点85个,其中上调49个,下调36个。MALDI-ToF-ToF质谱鉴定出其中的26种,包括内质网蛋白、线粒体蛋白、分子伴侣、结构蛋白和抗氧化蛋白等。结论通过蛋白质组学方法的研究,探索了雷帕霉素损伤人冠状动脉内皮细胞的一些特定蛋白质变化。 Objective To explore the molecular mechanisms of the effect of eluting stent drug rapamycin for injuring human coronary artery endothelial cells (HCAECs) by using the proteomics method. Methods HCAECs were treated with rapamycin,and the differentially expressed proteins were analyzed by two dimension fluorescence differential gel electrophoresis(2D-DIGE). The changed proteins were identified by MALDI-ToF-ToF. Results At least 85 differential protein spots were found,including 49 up- regulated and 36 down-regulated protein spots. Twenty-six proteins were identified by MALDI-ToF-ToF,including the endoplasmic reticulum protein, mitochondrial protein, molecular chaperones, ubiquitin system related protein, structural protein and oxidative stress related proteins,etc. Conclusion The changes of specific proteins of HCAECs injury induced by rapamycin are investigated by the proteomic method.
出处 《重庆医学》 CAS 2018年第8期1009-1011,1015,共4页 Chongqing medicine
基金 国家自然科学基金青年项目(81300151) 广东省省级科技计划项目(2016A020215163)
关键词 雷帕霉素 支架洗脱药物 人冠脉内皮细胞 分子机制 蛋白质组学研究 rapamycin eluting-stent-drug human coronary artery endothelial cells molecular mechanisms proteomic study
  • 相关文献

参考文献2

二级参考文献16

  • 1徐颖,刘骏,叶天舟,陆宁,贺桂彬.急性冠脉综合征介入治疗疗效观察[J].海南医学,2007,18(9):48-48. 被引量:3
  • 2Kim HK,Jeong MH. Gorcnary stent tlarombosis: currentinsights into new drug-eluting stent designs[J]. Chonnam Med J,2012,48(3) :141-14.9.
  • 3Kolandaivelu K, Swaminathan R, William J, et al. Stent thrombogenicity erly in high risk interventionaI settings is driven by stent design and deployment, and protected hy Ploymer-Drug coatings[J]. Circulation, 2011,123 ( 13 ) : 1400-1409.
  • 4Mehta SR,Tanguay JF,Eikelhoom JW, et al, Double-dose versus standard dose clopidogrel aud high-dose versus low-dose aspirin in individuals undergoing precutaneous coronary intervention for acute coronary syndromes (CURRENT-()ASIS7) : a randomized factorial trial [J ]. Lancet,2010,376(9748): 1233-1243.
  • 5Cutlip DE, Windecker S, Mehran R. el. a]. Academic re- search consortium, clinical end points in coronary stent trials:a case for standardized definitions[J]. Circulation, 2007,115(17) :2344-2351.
  • 6Frobert O,Sarno (;,James SK,et al. Effect of slent infla tion pressure and post-dilatation on the outcome of coro nary artery intervention. A report of more than 90000 stent implantations[J]. PLoS One, 2013,8 ( 2 ) : e56 a48.
  • 7Mehta SR, Bassand JP, Chrolavicius S, et al. Design and rationale of CURRENT-OASIS 7 : a randomized, 2 X 2 fac torial trial evaluating optimal dosing strategies for clopi dogrel and aspirin in patients with ST and non-ST eleva- tion acute coronary syndromes managed with an early in vasive stragety[J]. Am Heart J ,2008,156(6) = 1080-1088.
  • 8Bleeker GB, Bax J J, Fung JW, et al. Clinical verscs echo- cardiographic parameters to cardiac resynchronization therapy[J]. AM J Cardiol,2006,97(2) :260-263.
  • 9Lisa J,Chinami M, George R, et al. Patient seletion and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy[J]. Circulation, 2008,117 (15) : 2009-2023.
  • 10陈健.急性心肌梗死静脉溶栓后介入治疗与直接介入治疗的对比研究[J].重庆医学,2012,41(3):295-296. 被引量:43

共引文献1

同被引文献26

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部